Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with peripheral neuropathy (damage to the nerves outside the brain and spinal cord) based on both a physical examination and nerve testing, and the condition has been present for at least 6 months.
- People who have nerve pain that is clearly linked to their neuropathy, confirmed by scoring 4 or more out of 10 on a specific nerve pain questionnaire called the DN4.
- People whose average daily ongoing pain rates 4 or higher on a scale of 0 to 10.
- People aged between 18 and 80 years old.
- People who are enrolled in the French social security system.
- People who are able to understand and sign a consent form agreeing to take part in the trial.
Who may not be able to join:
- People who have another neurological condition (such as a neurodegenerative disease, migraines, epilepsy, stroke, or a brain tumour) or a psychiatric illness.
- People for whom the trial's brain stimulation procedure (called TMS) would be unsafe — for example, those who have metal implants inside their skull.
- People who have epilepsy that is active or has not been controlled by treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 800-555-5555
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Interference Scale of the short form of the Brief Pain Inventory (BPI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.